Experimental Type 1 Diabetes Drug Shields Pancreas Cells from the Usual Crippling Immune System Attack
Scientists at Johns Hopkins say that an experimental antibody drug appears to prevent and reverse the onset of type 1 diabetes in mice—and often lengthen their lives. The drug called mAb43 is unique, according to the researchers, because it targets insulin-making beta cells in the pancreas directly and is designed to shield those cells from […]
The post Experimental Type 1 Diabetes Drug Shields Pancreas Cells from the Usual Crippling Immune System Attack appeared first on Good News Network.
from All News Archives – Good News Network https://ift.tt/QG4Oydz